Global Clinical Trial Imaging Market Report is Poised to Reach at a Healthy CAGR of +6.9% by 2024

Clinical Trial Imaging Market accounted to USD 775.1 million in 2016 growing at a healthy CAGR growth during the forecast period of present to 2024. The Global Clinical Trial Imaging Market By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography), By Products (Services & Software), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic & Government Research Institutes), By Geography – Forecast to 2024

Request for a Free Sample Copy of this Report @

Some of the major players operating in clinical trial imaging market are:

Bioclinica, PAREXEL International Corporation, ICON plc., IXICO PLC., Intrinsic Imaging, LLC,  ERT Clinical, BioTelemetry, Inc., Cardiovascular Imaging Technologies, Radiant Sage LLC, WorldCare Clinical, VirtualScopics, Prism Clinical Imaging, Medical Metrics Inc., Mint Medical GmbH, Image Core Lab., Bioxydyn, Biomedical Systems, Clarity Pharmaceuticals, Quotient Clinical and BANOOK GROUP among others.

Target Audience

Government Associations

Consultants/Consultancies/Advisory Firms

Network Service Providers

Academic And Research Institutes

Support And Maintenance Service Providers

Are among others mentioned in the report.

Market Segmentation: Global Clinical Trial Imaging Market

The global clinical trial imaging market is segmented by modality computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray and echocardiography.

By products the market segmented into services and software. Services are further sub segmented into read analysis service, design consulting, operational imaging services, system & technology support services and trial design consulting services.

By end user the market segmented into pharmaceutical companies, biotechnology companies, contract research organizations and academic & government research institutes.

On the basis of geography, clinical trial imaging market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

Competitive Analysis: Global Clinical Trial Imaging Market

The clinical trial imaging market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of clinical trial imaging market for global, Europe, North America, Asia Pacific and South America.

Reason to buy the Report:

It helps to know that the global clinical trial imaging market product sections along with their future forecast.

It aims for making informed business decisions by utilizing a comprehensive analysis of market sections and from having whole insights of global clinical trial imaging market.

It poses a forward-looking prospect on distinct facets controlling and global clinical trial imaging market.

This poses a six-year global clinical trial imaging market forecast assessment primarily based mostly on the way the sectors are anticipated.

Global clinical trial imaging market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is present to 2024.

Download Detailed TOC @


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *